Panitumumab
In the US, Panitumumab (panitumumab systemic) is a member of the drug class EGFR inhibitors and is used to treat Colorectal Cancer.
US matches:
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
L01XC08
CAS registry number (Chemical Abstracts Service)
0339177-26-3
Chemical Formula
C6398-H9878-N1694-O2016-S48
Molecular Weight
142346
Therapeutic Categories
Antineoplastic agent
Immunomodulator
Monoclonal antibody against epidermal growth factor receptor
Chemical Names
Immunoglobulin, anti-(human epidermal growth factor receptor) (human monoclonal ABX-EGF heavy chain), disulfide with human monoclonal ABX-EGF light chain, dimer (WHO)
Immunoglobulin, human (anti-human epidermal growth factor receptor) monoclonal antibody (ABX-EGF)
Foreign Names
- Panitumumabum (Latin)
- Panitumumab (German)
- Panitumumab (French)
- Panitumumab (Spanish)
Generic Names
- Panitumumab (OS: BAN)
- ABX-EGF MAb (IS)
- anti-EGFr MAb (IS)
- rHuMAB-EGFr (IS)
Brand Names
- Vectibix
Amgen, Austria; Amgen, Australia; Amgen, Belgium; Amgen, Canada; Amgen, Czech Republic; Amgen, Germany; Amgen, Spain; Amgen, Finland; Amgen, France; Amgen, United Kingdom; Amgen, Greece; Amgen, Israel; Amgen, Iceland; Amgen, Luxembourg; Amgen, Latvia; Amgen, Netherlands; Amgen, Norway; Amgen, Romania; Amgen, Sweden; Amgen, Slovenia; Amgen, Slovakia; Amgen, United States; Amgen Europe, Denmark; Amgen Europe, Lithuania; Amgen Europe - NL, Italy; Amgen Ltd., Ireland; Amgen Switzerland, Switzerland; Oktal, Croatia (Hrvatska)
International Drug Name Search
Glossary
| Term | Definition |
|---|---|
| BAN | British Approved Name |
| IS | Inofficial Synonym |
| OS | Official Synonym |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| WHO | World Health Organization |
Click for further information on drug naming conventions and International Nonproprietary Names.
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
